Oxford Vaccine Dosage
- All
- News
-
AstraZeneca-Oxford Covid Vaccine Cleared By UK As It Fights Mutant Virus
- Wednesday December 30, 2020
- World News | Reuters
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
- www.ndtv.com
-
UK Medicine Regulator To Assess Best Dose For Oxford COVID-19 Vaccine
- Wednesday December 9, 2020
- World News | Reuters
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
- www.ndtv.com
-
Oxford Vaccine's Counter To Mounting Criticism: A New Global Trial
- Thursday November 26, 2020
- World News | Suzi Ring and James Paton, Bloomberg
AstraZeneca Plc's Covid-19 vaccine looks like it's headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study.
- www.ndtv.com
-
AstraZeneca-Oxford Covid Vaccine Cleared By UK As It Fights Mutant Virus
- Wednesday December 30, 2020
- World News | Reuters
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
- www.ndtv.com
-
UK Medicine Regulator To Assess Best Dose For Oxford COVID-19 Vaccine
- Wednesday December 9, 2020
- World News | Reuters
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
- www.ndtv.com
-
Oxford Vaccine's Counter To Mounting Criticism: A New Global Trial
- Thursday November 26, 2020
- World News | Suzi Ring and James Paton, Bloomberg
AstraZeneca Plc's Covid-19 vaccine looks like it's headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study.
- www.ndtv.com